Once again, ole HC has to provide breaking news to this
Once again, ole HC has to provide breaking news to this message board.
If you look on their website (shop / Order Now section) you will find a BOGO on Eject Delay. Say what HC, you fool - so freakin what? Well it is a great deal folks but I'm just playin with ya. The real news is AllerVarx is now available for purchase at $49.95. Another NEW product that WILL add to revs and their bottom line.
ProstaGorx and AllerVarx now. THANK ME by buying some product, telling 3 friends, and post/tweet about it.
1
Innovus Pharmaceuticals Inc. (INNV) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...
Continue Reading
Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...
Continue Reading
Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...
Continue Reading
Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...
Continue Reading
Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...
Continue Reading
A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...
Continue Reading
Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...
Continue Reading
You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...
Continue Reading
Solvang Strikers Prevail with New Deal Staring down the barrel of a five-week standoff, the hard-nosed workers of Solvang just proved exactly what grit can get you. The City of Solvang and the steadfast members of Teamsters Local 986 wrapped up their punchy back-and-forth by clinching a contract that ups the ante on wages and job respect. For a bunch who stuck it out on...
Continue Reading
Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...
Continue Reading
Top 5 Most Recently Viewed Articles
Revolutionizing Newborn Screening with Genome Sequencing In a groundbreaking development, the GUARDIAN study has ushered in potential transformative benefits for newborn screening. This innovative research integrates genome sequencing into standard newborn screening processes, significantly improving the detection of early onset genetic conditions in infants. Conducted by...
Continue Reading
A Critical Diplomatic Meeting Unfolds Leaders from Europe, including President Volodymyr Zelenskyy, are converging in Washington to engage in crucial discussions with the U.S. administration. This high-stakes meeting comes in light of the ongoing conflict in Ukraine, which has heightened tensions on the global stage. European Leaders Stand with Ukraine The gathering will...
Continue Reading
Understanding the Class Action Lawsuit Against iRobot Corporation In today's dynamic investment landscape, it's crucial for shareholders to stay informed about significant legal actions that may affect their investments. Recently, a class action lawsuit has been initiated against iRobot Corporation (NASDAQ: IRBT), drawing the attention of investors who might have been...
Continue Reading
First Interstate BancSystem, Inc. Plans Q4 Earnings Call Event First Interstate BancSystem, Inc. (NASDAQ: FIBK), the parent company of First Interstate Bank, is set to report its fourth quarter results following the market closure. This anticipated announcement will occur on a Wednesday, with a conference call scheduled for Thursday morning. During this call, company...
Continue Reading
MicroStrategy's New Proposal for Stock Increase MicroStrategy Incorporated (NASDAQ: MSTR) is making waves in the financial world by seeking shareholder approval to substantially increase its authorized shares. This strategic move is primarily aimed at raising funds to enhance its bitcoin acquisitions. With a bold approach, the company plans to expand its authorized class...
Continue Reading